![Timothy Nelson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Nelson
Direttore/Membro del Consiglio presso
IPI LEGACY LIQUIDATION CO
Profilo
Timothy S.
Nelson is currently the Chairman at Xoc Pharmaceuticals, Inc., an Independent Director at Impel Pharmaceuticals, Inc., a Director at Dermavant Sciences, Inc., and an Independent Director at Dermavant Sciences Ltd. He is also a Director at Roivant Sciences, Inc. Timothy's former positions include being the President, Chief Executive Officer & Director at MAP Pharmaceuticals LLC, Chairman at Civitas Therapeutics, Inc., Business Director-Neurological Division at Medtronic, Inc., Independent Director at Surmodics, Inc., and Senior VP-Commercial & Business Development at DURECT Corp.
Mr. Nelson received his undergraduate degree from the University of Minnesota and his graduate degree from Kellogg School of Management.
Posizioni attive di Timothy Nelson
| Società | Posizione | Inizio |
|---|---|---|
| IPI LEGACY LIQUIDATION CO | Direttore/Membro del Consiglio | 01/02/2017 |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Operates as a a biotechnology company focused on dermatology | Direttore/Membro del Consiglio | 15/05/2019 |
Dermavant Sciences Ltd.
 Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapeutics in immuno-dermatology | Direttore/Membro del Consiglio | 01/04/2019 |
Xoc Pharmaceuticals, Inc.
 Xoc Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel oral therapies for migraine prevention and dopamine agonism parkinson’s disease management | Presidente | 01/01/2018 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Timothy Nelson
| Società | Posizione | Fine |
|---|---|---|
| SURMODICS | Direttore/Membro del Consiglio | 03/03/2015 |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Presidente | 01/10/2014 |
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Amministratore Delegato | 01/03/2013 |
| DURECT | Corporate Officer/Principal | 01/01/2005 |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Timothy Nelson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
64
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for hypertension care | Health Technology |
Surmodics, Inc.
 Surmodics, Inc. Medical SpecialtiesHealth Technology Provides surface modification and in vitro diagnostic technology services to the healthcare industry | Health Technology |
DURECT Corp.
 DURECT Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for pain and chronic diseases | Health Technology |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Health Technology |
Impel Pharmaceuticals, Inc.
 Impel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late-stage biopharmaceutical company focused on developing transformative therapies for central nervous system disorders | Health Technology |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Operates as a a biotechnology company focused on dermatology | Health Technology |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Xoc Pharmaceuticals, Inc.
Xoc Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel oral therapies for migraine prevention and dopamine agonism parkinson’s disease management | Commercial Services |
Dermavant Sciences Ltd.
Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapeutics in immuno-dermatology | Health Technology |
